Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
66 /100
HIGH RISK
Score updated Aug 28, 2026

BCTX — BriaCell Therapeutics Corp. Dilution Risk Tracker

Track BCTX dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track BCTX — Get alerts when the score changes →

As of August 28, 2026, BriaCell Therapeutics Corp. (BCTX) has a DilutionWatch DilutionScore of 66/100, rated HIGH dilution risk. BriaCell Therapeutics Corp. has a market capitalization of $26.39M, 8.70M shares outstanding, 16 institutional holders tracked. Stored dilution-related fields include shelf registration capacity of $25.00M.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
90
💰 Cash Runway
65
📊 Float Risk
30
⚠️ Warrant Exposure
40
🔄 Convertible Debt
40

Dilution Forecast

Watch
Minor dilution signals detected
model est. 20%
💰 Capital Raise model 35%
• Under 12 months cash (11mo)
• Active shelf registration ($25M, 95% of market cap)
📉 Score Deterioration model 10%
• Score in HIGH risk zone (66/100)
🔔 Track BCTX — Get forecast alerts →

Market Data

Market Cap$26.39M
Shares Outstanding8.70M
Float6.41M
Cash$22.80M
DebtN/A
Short InterestN/A

Institutional Holdings

16 institutional holders · 390.4K shares
#1 Cable Car Capital, LP 216.8K shares
#2 SABBY MANAGEMENT, LLC 73.9K shares
#3 IRIDIAN ASSET MANAGEMENT LLC/CT 65.0K shares
+ 13 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest408.3K
Days to Cover6.0
% of Float6.4%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL WARRANT 2025-07-31
xbrl XBRL CONVERTIBLE 2021-07-31
8-K 8K EVENT 2026-02-20
8-K 8K EVENT 2026-01-15
EFFECT EFFECT 2026-01-13
Full SEC filing analysis available with free account

Recent News

No recent news

Factual BCTX Dilution Snapshot

BriaCell Therapeutics Corp. (BCTX) has a DilutionScore of 66/100, rated High dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track BCTX Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking BCTX — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

→ Biotech / Pharma sector dilution risk overview

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for BCTX
BCTX FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.